4Life® Transfer Factor™ - Latest News
Factor® Products Included in 2013 Physicians’ Desk Reference
Salt Lake City, Utah
(January 8, 2013) 4Life executives are pleased to
announce that 4Life Transfer Factor® products are listed
in the 2013 Physician’s Desk Reference (PDR).
“We are thrilled to be part of this prestigious and
valuable publication. This is the ninth year that 4Life
products have been listed,” stated Director of Product
Development Chad Renshaw. “The PDR is among the most
substantiated resources in the medical community and is
distributed to 500,000 health professionals across the
United States. Having 4Life products included provides
distributors with unrivaled credibility when presenting
our products to customers.”
The 2013 edition of the PDR provides in-depth product
information about 4Life Transfer Factor® and 4Life®
Transfer Factor Plus® Tri-Factor® Formulas. In addition,
the publication offers a technical description of the
product line and synopses on several scientific studies.
With nine worldwide patents and dozens more pending, an
in-house Research and Development team, the scientific
input of the Health Sciences Advisory Board, and the
industry’s only immunological testing lab, 4Life’s
commitment to Transfer Factor science is well
Director of Health Information Systems Brent Vaughan:
“This professional listing is an invaluable asset for
4Life distributors. The publication strengthens the
field’s position as exclusive leaders in the
distribution of 4Life Transfer Factor products.”
4Life has offices on five continents to serve a global
network of independent distributors through science,
success, and service.
4Life Transfer Factor®
Products Approved for Use by Olympic Athletes
Salt Lake City, Utah (December 4, 2007)
As first reported by 4Life Chief Scientific
Officer Calvin McCausland, Ph.D., in Direct
Selling News, 4Life received documentation
from the Federal Anti-Doping Center in
Moscow, Russia, that admits 4Life Transfer
Factor for use by Olympians in practice,
training, and competition. Approval was
obtained after volunteers consumed 4Life
Transfer Factor products and their bodily
fluids were analyzed in accordance with
doping control procedures that employ modern
methods of gas chromatography and
mass-spectrometry in compliance with the
World Anti-Doping Agency in Montreal,
“We are very pleased by this approval,”
commented President of Eurasia Emma Oganova,
M.D., Ph.D. “4Life Transfer Factor continues
to define the cutting-edge of immune system
4Life Founder and Chief Executive Officer
David Lisonbee launched 4Life Research in
1998 with a commitment to the highest
scientific standards. Ongoing research and
development of Transfer Factor technology
has fueled 4Life’s constant growth and
maximized every distributor’s ability to
grow a successful independent business.
“Arguably, this kind of marketplace
positioning and high level product messaging
simply isn’t possible without the
involvement of a professional research and
development team,” added McCausland.
“I am pleased with our continued evolution
in the supplement industry,” stated
Executive Vice President Bruce Redd. “The
quality work of our Research and Development
department is certain to keep 4Life on the
leading edge of science and success for
years to come.”
4Life, the leader in the development,
production, and distribution of Transfer
Factor support products, continues to post
growth in more than 40 countries around the
4Life Research Announces New
September 21, 2007 (Salt Lake City, Utah) 4Life
Research™, the world leader in Transfer Factor science
and immune system support development, announced today
the discovery of immune activity in a weight range of
molecules significantly smaller than transfer factors.
Transfer factors are molecules in
a weight class between 3,500 - 12,000 daltons that help the immune system
recognize, respond to, and remember outside threats. Although scientists have
known that smaller molecules than transfer factors existed within cow colostrum,
their significance in terms of immune activity has been unknown until now.
In 2005, 4Life Chief Executive
Officer David Lisonbee and the Research and Development department began
studying these low weight molecules. After two years of research, 4Life clinical
findings now indicate that molecules in a weight range between 250 — 3,000
daltons play important regulatory roles in the immune system.
4Life extracted and concentrated
these nanofraction molecules from cow colostrum for their proprietary
extract, combining NanoFactor with their exclusive Transfer Factor E-XF™ extract
of transfer factors from cow colostrum and chicken egg yolks to produce 4Life
Transfer Factor® Tri-Factor™ Formula, the most comprehensive approach to immune
system support available today.
"I don't know of another company
in our category," said 4Life Chief Scientific Officer Calvin McCausland, Ph.D.
"In 2004, we were the first company to combine transfer factors from cow
colostrum and chicken egg yolks. In 2005, we introduced RioVida®, the world's
only transfer factor beverage. Now, the discovery of new immune activity in
nanofractions. When it comes to scientific innovation, there's simply no
comparison to 4Life."
4Life Transfer Factor, Transfer
Factor Plus®, and RioVida are now fortified with the new Tri-Factor Formula.
"We're taking Tri-Factor Formula to the world because no other product
represents such a unique and indispensable opportunity for a quality life,"
remarked 4Life President Steve Tew.
David Lisonbee: "At the end of
the day, our distributors can rest assured that 4Life will stay a good pace
ahead of the curve in the areas of science, service, and success."
4Life, global leader in the
development, production, and distribution of Transfer Factor immune support
products, continues to post growth in more than 40 countries around the world.
Transfer Factor™ Now Approved By the Health Ministry of
Russia for use in Hospitals and Clinics!
First Ever Dietary Supplement to be
Approved for Use by Doctors and Hospitals in Russia
SANDY, UT (October
1, 2004) - In an unprecedented announcement in the history of network marketing,
4Life announced today that 4Life Transfer Factor products as immune modulators
have been approved for use in hospitals and clinics in the Russian Federation.
The results of ten separate clinical trials and two experimental studies on
4Life Transfer Factor products were combined in a Methodological Document that
was approved by the Ministry of Health, which now allows doctors to recommend
4Life Transfer Factor Classic and 4Life Transfer Factor Plus® products to their
Supplement Approved for Use by Doctors and Hospitals in Russia
Commenting on this
remarkable achievement, David Lisonbee, CEO of 4Life stated, “To my knowledge,
this is the first time in the history of this industry that a network marketing
company or any other dietary supplement company has had one of its dietary
supplements approved for use in hospitals in Russia. The Russian Ministry of
Health is the equivalent of the Food and Drug Administration in the United
States. Doctors and scientists from Russia have been working jointly with
scientists from 4Life for several years to arrive at this accomplishment. This
approval establishes a new roll of dietary supplements in the Russian health
Response from Russian Academy of Medical Sciences
In another sector
of research of 4Life Transfer Factor, Dr. Kisielevsky of the Russian Academy of
Medical Sciences stated, “The 4Life sample [Transfer Factor Advanced Formula]
activated NK (natural killer) cell activity more than the Interleukin-2 (IL2)
drug we used as the standard.” This discovery has attracted the attention of The
International Scientific and Technical Center (ISTC) of Russia.
Several Countries Join Forces for Additional Clinical Studies of Transfer Factor
The ISTC of Russia
is a member of a joint international project with other health agencies of
Japan, Europe and the US. The objective of the international project is to
combine efforts in finding improved immunotherapies. Following the discoveries
from the NK cell testing, the scientists of 4Life have been invited to join the
project. 4Life Transfer Factor as an immune modulator will be further researched
in this international forum. The cost of the studies will be paid by the ISTC.
Speaking of this
benchmark achievement, Dr. Calvin McCausland, VP of Research of 4Life, and Dr.
Emma Oganova, 4Life/Eurasia President, jointly expressed that because of the
acceptance by such a reputable organization and doctors from Russia and other
major countries, 4Life Transfer Factor will gain wider acceptance in the
professional and private sectors as a superior immune system enhancing product.
The worldwide ramifications to this acceptance are just beginning.
4Life Research is
the World’s foremost leader in the development, production and distribution of
natural immune support products and was recently recognized by Inc.
magazine as the fifteenth fastest growing privately-held company in America.
Clinical Studies |
TF & NK Cells
How To Order
TF & Pets
| Biz Opportunity